Estrogens activate bone morphogenetic protein-2 gene transcription in mouse mesenchymal stem cells

Shuanhu Zhou, Gadi Turgeman, Stephen E. Harris, Dale C. Leitman, Barry S. Komm, Peter V.N. Bodine, Dan Gazit

Research output: Contribution to journalArticle

108 Scopus citations

Abstract

Estrogens exert their physiological effects on target tissues by interacting with the estrogen receptors, ERα and ERβ. Estrogen replacement is one the most common and effective strategies used to prevent osteoporosis in postmenopausal women. Whereas it was thought that estrogens work exclusively by inhibiting bone resorption, our previous results show that 17β-estradiol (E2) increases mouse bone morphogenetic protein (BMP)-2 mRNA, suggesting that estrogens may also enhance bone formation. In this study, we used quantitative real-time RT-PCR analysis to demonstrate that estrogens increase BMP-2 mRNA in mouse mesenchymal stem cells. The selective ER modulators, tamoxifen, raloxifene, and ICI-182,780 (ICI), failed to enhance BMP-2 mRNA, whereas ICI inhibited E2 stimulation of expression. To investigate if estrogens increase BMP-2 expression by transcriptional mechanisms and if the response is mediated by ERα and/or ERβ, we studied the effects of estrogens on BMP-2 promoter activity in transient transfected C3H10T1/2 cells. E2 produced a dose-dependent induction of the mouse -2712 BMP-2 promoter activity in cells cotransfected with ERα and ERβ. At a dose of 10 nM E2, ERα induced mouse BMP-2 promoter activity 9-fold, whereas a 3-fold increase was observed in cells cotransfected with ERβ. Tamoxifen and raloxifene were weak activators of the mouse BMP-2 promoter via ERα, but not via ERβ. ICI blocked the activation of BMP-2 promoter activity by E2 acting via both ERα and ERβ, indicating that mouse BMP-2 promoter activation is ER dependent. In contrast to E2 and selective ER modulators, the phytoestrogen, genistein was more effective at activating the mouse BMP-2 promoter with ERβ, compared with ERα. Using a deletion series of the BMP-2 promoter, we determined that AP-1 or Sp1 sites are not required for E2 activation. A mutation in a sequence at -415 to -402 (5′-GGGCCActcTGACCC-3′) that resembles the classical estrogen-responsive element abolished the activation of the BMP-2 promoter in response to E2. Our studies demonstrate that E2 activation of mouse BMP-2 gene transcription requires ERα or ERβ acting via a variant estrogen-responsive element binding site in the promoter, with ERα being the more efficacious regulator. Estrogenic compounds may enhance bone formation by increasing the transcription of the BMP-2 gene.

Original languageEnglish (US)
Pages (from-to)56-66
Number of pages11
JournalMolecular Endocrinology
Volume17
Issue number1
DOIs
StatePublished - Jan 1 2003

ASJC Scopus subject areas

  • Molecular Biology
  • Endocrinology

Fingerprint Dive into the research topics of 'Estrogens activate bone morphogenetic protein-2 gene transcription in mouse mesenchymal stem cells'. Together they form a unique fingerprint.

  • Cite this

    Zhou, S., Turgeman, G., Harris, S. E., Leitman, D. C., Komm, B. S., Bodine, P. V. N., & Gazit, D. (2003). Estrogens activate bone morphogenetic protein-2 gene transcription in mouse mesenchymal stem cells. Molecular Endocrinology, 17(1), 56-66. https://doi.org/10.1210/me.2002-0210